Skip to Content

GX EJ7 (Epivir 300 mg)

Generic Name: lamivudine

Pill with imprint GX EJ7 is Gray, Four-sided and has been identified as Epivir 300 mg. It is supplied by GlaxoSmithKline.

Epivir is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX EJ7

Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7 Front
Epivir 300 mg GX EJ7 Back
Epivir 300 mg GX EJ7

Epivir

Generic Name
lamivudine
Imprint
GX EJ7
Strength
300 mg
Color
Gray
Size
17.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)
00173-0714
Inactive Ingredients
ferric oxide black, hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.